Successful Ovulation in Plasminogen-deficient Mice Treated with the Broad-spectrum Matrix Metalloproteinase Inhibitor Galardin.
From: Department of Medical Biochemistry and Biophysics, Umeå University, SE-901 87 Umeå, Sweden.
Developmental biology
- Publish Date: Jul 2006
- ISSN: 0012-1606
- Volume: 295
- Issue: 2
- Pages: 615-22
- Medium: Print
- Language: English
- Citation (JAMA): Liu Kui, Wahlberg Patrik, Leonardsson Göran, et al. Successful Ovulation in Plasminogen-deficient Mice Treated with the Broad-spectrum Matrix Metalloproteinase Inhibitor Galardin.. Dev. Biol. Jul 2006;295:615-22
Abstract
Many studies have suggested the hypothesis that the plasminogen activator (PA) system and the matrix metalloproteinase (MMP) system, either separately or in combination, may provide the proteolytic activity that is required for rupture of the follicular wall at the time of ovulation. Our recent studies on ovulation in plasminogen (plg)-deficient mice have, however, shown that plasmin is not required for normal ovulation, leading us to the hypothesis that MMPs may be a more important source of proteolysis for this process. To investigate the role of MMPs and also the possibility of a functional overlap or synergy between the MMP and PA systems during ovulation, we have studied ovulation efficiency in wild-type and plg-deficient mice treated with the broad-spectrum MMP inhibitor galardin. We found that in both wild-type mice and heterozygous plg-deficient (plg+/-) mice that had been treated with galardin prior to ovulation, there was a mild (18-20%) reduction in ovulation efficiency. Surprisingly, galardin treatment of plg-deficient (plg-/-) mice only caused an additional 14% reduction in ovulation efficiency as compared to vehicle-treated plg-/- mice. Our data therefore suggest that although MMPs may play a role in degradation of the follicular wall, they may not be obligatory for ovulation. In contrast to previous studies on tissue remodeling during wound healing and placental development, we have demonstrated that there is no obvious functional overlap or synergy between the PA and MMP systems, which has previously been thought to be essential for the ovulatory process.
Mesh Headings (Keywords): Animals, Dipeptides, Enzyme Inhibitors, Female, Matrix Metalloproteinases, Mice, Mice, Knockout, Ovarian Follicle, Ovulation, Plasminogen, Plasminogen Activators
Check for Full Text / PubMed Unique Identifier (PMID): 16712832
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.